Hyperbaric hyperoxemia as a risk factor for ventilator-acquired pneumonia?
<h4>Objectives</h4>Ventilator-acquired pneumonia (VAP) is the leading cause of serious associated infections in Intensive Care Units (ICU) and is associated with significant morbidity. The use of hyperbaric oxygen therapy (HBOT) in patients on mechanical ventilation may increase exposure...
Guardado en:
Autores principales: | Morgan Caplan, Thibault Duburcq, Anne-Sophie Moreau, Julien Poissy, Saad Nseir, Erika Parmentier-Decrucq |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d8a2991175a41448bb78f34d4a27832 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Extracorporeal Membrane Oxygenation for COVID 2019-Acute Respiratory Distress Syndrome: Comparison between First and Second Waves (Stage 2)
por: Nicolas Dognon, et al.
Publicado: (2021) -
Epidemiology, etiology, and diagnosis of health care acquired pneumonia including ventilator-associated pneumonia in Nepal.
por: Sabina Dongol, et al.
Publicado: (2021) -
Epidemiology, etiology, and diagnosis of health care acquired pneumonia including ventilator-associated pneumonia in Nepal
por: Sabina Dongol, et al.
Publicado: (2021) -
Risk factors of ventilator-associated pneumonia in elderly patients receiving mechanical ventilation
por: Xu Y, et al.
Publicado: (2019) -
Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients
por: A. Premachandra, et al.
Publicado: (2021)